WPA LOGO
November 2010
IV. National Course on Dual Pathology and Gender, 22 September 2010, Barcelona, Spain

Hypnosedatives, Dual Pathology and Female Gender

The success of past courses, 2007 (Cocaine), 2008 (Alcohol), and 2009 (Cannabis), obtained by the Sociedad Española de Patología Dual, focused on Dual Pathology and Gender, have encouraged us to organize this Fourth edition on Hypnosedatives, Dual Pathology and Woman.

The Society’s Board and Local board have taken upon themselves the coordination of this course placing it in Barcelona; the local institutions have given strong support to make it possible and it took place at the Caixa-Forum building. More than 350 clinicians, mainly psychiatrists and psychologists attended this meeting.

Research in analysis of gender in the area of Dual Pathology is relatively recent, although the fact of being male or female conforms and conditions the way addiction pathology is expressed, as it is often the case, with other psychiatric disorders. Although the differences between male and female are well documented, the research approach rarely considers the gender. In general the research, prevention and treatment of both psychopathologic signs are considered from the “male´s” position.

The differences in females’ dual pathology are related with phenomena both neurobiological and psychosocial, as well as with the structure of the individual, the family and the social network in which the subject is immersed. The stage of the woman, as a subject in itself, is placed in an evolutive-historic-social network.

Our society has lived great changes in the past century regarding the female’s role. Today women have more professional and educational opportunities although negative differences in salaries, positions or others still prevail.

Women’s incorporation to society in a more egalitarian position has also carried their incorporation to its more negative sides such as abuse of alcohol, benzodiacepines or other drugs which are accompanied by diverse psychopathologic disorders emphasizing those characteristics prevailing in women.  

The prevalence of prescription of Hypnosedatives in Spain is high; Benzodiacepines and other hypnosedative drugs are the drugs more frequently consumed in our society, mainly in the case of women. When this in-take becomes an addiction it generally shows by the presence of diverse psychopathologic disorders such as anxiety or depression, or others which present in women clearly differentiated characteristics.

The knowledge of these biologic and socio-cultural differences by clinicians has to have a different clinical and therapeutic approach in women.

 

« Back
Send this to a colleague